SECTION 1.       Pursuant to its powers under Section 36(a) of Republic Act No. 6425 as amended the Dangerous Drugs Board, having found after evaluation that the following substances:

INTERNATIONAL NON-PROPRIETARY NAME ( INN)	CHEMICAL NAME	OTHER NAME
N-hydroxy MDA	((+) -N-[alpha-methyl-3- 4-(methylenedioxy) phenethy 1] hydroxy- lamine)	3, 4 methylene-dioxy-N-hydroxyamphetamine; N-hydroxy-3,4- methylenedioxy- amphetamine: N-OH-MDA; N-hydroxy-3,4- methylenedioxy- phenylisopropy-lamine 1-3(3,4-methy-lenedioxyphenyl)-2 hydroxy-aminopropane
N-ethyl MDA	((+)-N-ethyl-alpha methyl-3,4 (methy- lenedioxy) phene- thylamine))	3,4-methylene-dioxy-N-ethy- lamphetamine; N-ethyl-3,4- methylenedioxy-amphetamine; Eve; MDEA; N-ethyl-3,4- methylenedioxy-phenylisopropy- lamine; 1-(3,4-methyle-nedioxy-phenyl) -2-ethylamino-propane; 3-4-methylenedio-xyethampheta-mine
4-methylaminorex	((+)-cis-2amino-4 methyl-5-phenyl-2-oxazoline))	McN-822; Euphoria; U4Euh; ICE; d, 1-cis-2-amino-4- methyl-5-phenyl-2- oxazoline: d, 1-erthro-2-amino-4-methyl-5-phenyl-2-oxazoline

have the capacity to produce dependence and are likely to be so abused as to constitute a public health and social problem which finding is in agreement with the opinion of the World Health Organization that such substances should be included in Schedule I of the 1971 Convention on Psychotropic Substances, pursuant to Article II, paragraphs 1 and 4 of said Convention hereby classifies the said substances as Dangerous Drugs and further categorizes as Prohibited Drugs as well as their salts, isomers (whether optical position, or geometric) which (a) exist within the specific chemical designations by whatever official name common name or usual name, chemical name or brand name and (b) have the same or similar psychologic and/or physiologic effects as the parent drugs mentioned above.

SECTION 2.       All compounds, mixtures or preparations containing these substances and their salts, isomers, and salts of isomers qualified in Section 1 hereof are classified as Dangerous Drugs and further categorized as Prohibited Drugs.

SECTION 3.       In view of this classification, these Dangerous Drugs shall be subject to all control measures in Article II "Prohibited Drugs" and Article IV, "Provisions of Common Application to Offenses Penalized under Articles II and III," of Republic Act 6425, as amended and pertinent Regulations issued by the Dangerous Drugs Board.

SECTION 4.       Any violation hereof shall be a ground for the Institution of criminal proceedings in the proper court.

SECTION 5.       This Regulation supplements Board Regulation No. 5, Series of 1972 and shall take effect (15) days after the completion of its publication in a newspaper of general circulation once a week for two (2) consecutive weeks.

Adopted: 15 Feb. 1990

(SGD.) TOMAS P. MARAMBA JR., M.D. M.H.A
Vice-Chairman
(Undersecretary of Health for Standards and Regulation)